"Genscript"

Supplier: Genscript

The product is specific for daratumumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody Genscript, A01997 anti-daratumumab antibody (6A3).

Supplier: Genscript

The product is specific for Adalimumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01956-40, Anti- Adalimumab Antibody (3C2) [Biotin], mAb, Mouse.

Supplier: Genscript

THE™ Anti-GST Monoclonal antibody (Mouse) recognizes GST localized at the C-terminal, N-terminal and internal region ofGST-tagged fusion proteins.

Supplier: Genscript

GenScript MonoRab™ DYKDDDDK tag antibody [Biotin], mAb, rabbit specifically recognizes DYKDDDDK tags placed at C-terminal, N-terminal and internal regions of DYKDDDDK fusion proteins.

Supplier: Genscript

THE™ DYKDDDDK Tag antibody [HRP], mAb, Mouse recognizes C-terminal, N-terminal and internal tagged fusion proteins.

Supplier: Genscript

THE™ V5 Tag antibody, mAb, Mouse recognizes C-terminal, N-terminal and internal V5 tagged fusion proteins.

Supplier: Genscript

GenScript MBP-tag Antibody, mAb, Mouse specifically reacts with fusion proteins containing MBP epitope tags.

Supplier: Genscript

eZwest™ Lite is a fully automated western blotting device completing the entire process of blocking, antibody incubation, and washing steps. Automation of western blot incubation steps minimizes errors and variability typically associated with manual operations contributing to experimental reproducibility. eZwest frees researchers from the manual labor of traditional western blot.

Supplier: Genscript

The MonoRab™ Rabbit Anti-Camelid VHH Antibody [iFluor 647], mAb is specific for Camelid VHH (Alpaca, Llama and Camel). This monoclonal antibody has no cross-reactivity with mouse, rat, rabbit, chicken, goat or human immunoglobulins.

Supplier: Genscript

SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2), also known as 2019-nCoV, is a positive-sense single-stranded RNA virus. It caused coronavirus disease in 2019 (COVID-19). SARS-CoV-2 contains glycosylated spike (S) protein, which is composed of S1 subunit and S2 subunit. The S1 contains a receptor-binding domain (RBD) that can bind to ACE2 receptor on target cells.Neutralizing antibodies against SARS-CoV-2 can block the interaction between SARS-CoV-2 RBD and ACE2. The blocking ability of SARS-CoV-2 neutralizing antibodies is affected by its quantity. This standard product is intended for the calibration of SARS-CoV-2 neutralizing antibodies in the materials or samples. It can be used in the assessment and development of assays for the detection and quantitation of SARS-CoV-2 neutralizing antibodies. The neutralizing antibody standard binds to multiple neutralizing epitopes in the receptor-binding domain. This product has been verified to calibrate the quantitative assay of SARS-CoV-2 neutralizing antibody with the Surrogate Virus Neutralization Test (sVNT) (GenScript, Cat.No L00847-A), plaque reduction neutralization test (PRNT) and pseudovirus neutralization test (pVNT) (GenScript, Cat.No SC2087). Users can design assays to detect and evaluate the quantitation of SARS-CoV-2 neutralizing antibodies by this product.

Supplier: Genscript

The product is specific for SARS-CoV-2 Nucleocapsid protein.

Supplier: Genscript

THE™ NWSHPQFEK Tag antibody [FITC], mAb, Mouse recognizes N-terminal and C-terminal Strep II tagged fusion proteins.

Supplier: Genscript

THE™ HA Tag antibody [HRP], mAb, Mouse recognizes C-terminal, N-terminal and internal HA tagged fusion proteins.

Supplier: Genscript

THE™ GST antibody [HRP], mAb, Mouse recognizes C-terminal, N-terminal and internal tagged GST fusion proteins.

Supplier: Genscript

Omalizumab with trade name Xolair, is an FDA-approved drug for the treatment of moderate to severe persistent asthma in adults and adolescents (12 years of age and above). It is a recombinant humanized monoclonal antibody. It selectively binds to human immunoglobulin E (IgE). Omalizumab inhibits the binding of IgE to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. Anti-Omalizumab Antibody (7G11), mAb, Mouse is produced from a hybridoma resulting from the fusion of partner and B-lymphocytes obtained from a mouse immunized with omalizumab.

Supplier: Genscript

The product is specific for Bevacizumab. The antibody is recommended as a capture antibody in a pharmacokinetic (PK) bridging assay with detection antibody GenScript, A01976-40, Anti-Bevacizumab Antibody (6C3), mAb, Mouse.